Literature DB >> 9620990

Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

P M Smith1, Y Zhang, S R Jennings, D J O'Callaghan.   

Abstract

The cytolytic T-lymphocyte (CTL) response to respiratory infection with equine herpesvirus 1 (EHV-1) in CBA (H-2(k)) mice was investigated. Intranasal (i.n.) inoculation of mice with the attenuated EHV-1 strain KyA resulted in the generation of a primary virus-specific CTL response in the draining mediastinal lymph nodes 5 days following infection. EHV-1-specific CTL could be restimulated from the spleen up to 26 weeks after the resolution of infection, indicating that a long-lived memory CTL population was generated. Depletion of CD8+ T cells by treatment with antibody and complement prior to assay eliminated CTL activity from both primary and memory populations, indicating that cytolytic activity in this model was mediated by class I major histocompatibility complex-restricted, CD8+ T cells. A single i.n. inoculation with KyA induced protective immunity against infection with the pathogenic EHV-1 strain, RacL11. The adoptive transfer of splenocytes from KyA-immune donors into sublethally irradiated recipients resulted in a greater than 250-fold reduction in RacL11 in the lung. The elimination of both CD4+ and CD8+ T cells from the transferred cells abrogated clearance of RacL11, while the selective depletion of either subpopulation alone had little effect. These results suggested that both lymphocyte subpopulations contribute to viral clearance, with either subpopulation alone being sufficient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620990      PMCID: PMC110161     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge.

Authors:  A Stokes; D G Alber; R S Cameron; R N Marshall; G P Allen; R A Killington
Journal:  Virus Res       Date:  1996-10       Impact factor: 3.303

2.  Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium.

Authors:  D J Topham; R A Tripp; S R Sarawar; M Y Sangster; P C Doherty
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

3.  Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses.

Authors:  T Matsumura; D J O'Callaghan; T Kondo; M Kamada
Journal:  Vet Microbiol       Date:  1996-02       Impact factor: 3.293

4.  Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL.

Authors:  C F Colle; E B Tarbet; W D Grafton; S R Jennings; D J O'Callaghan
Journal:  Virus Res       Date:  1996-08       Impact factor: 3.303

5.  High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model.

Authors:  A Stokes; R S Cameron; R N Marshall; R A Killington
Journal:  Virus Res       Date:  1997-08       Impact factor: 3.303

6.  Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.

Authors:  J A Ellis; E Steeves; A K Wright; J R Bogdan; W C Davis; E W Kanara; D M Haines
Journal:  Vet Immunol Immunopathol       Date:  1997-07       Impact factor: 2.046

7.  Residence and recruitment of leucocytes to the equine lung after EHV-1 infection.

Authors:  J H Kydd; D Hannant; J A Mumford
Journal:  Vet Immunol Immunopathol       Date:  1996-06-15       Impact factor: 2.046

8.  Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.

Authors:  A Neubauer; M Beer; C Brandmüller; O R Kaaden; N Osterrieder
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

9.  Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo.

Authors:  B Polić; S Jonjić; I Pavić; I Crnković; I Zorica; H Hengel; P Lucin; U H Koszinowski
Journal:  J Gen Virol       Date:  1996-02       Impact factor: 3.891

10.  Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice.

Authors:  D G Alber; J Greensill; R A Killington; A Stokes
Journal:  Res Vet Sci       Date:  1995-11       Impact factor: 2.534

View more
  6 in total

1.  Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1alpha, 1beta, and 2 and tumor necrosis factor alpha.

Authors:  P M Smith; Y Zhang; W D Grafton; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

3.  Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.

Authors:  Patrick M Smith; Shannon M Kahan; Colin B Rorex; Jens von Einem; Nikolaus Osterrieder; Dennis J O'Callaghan
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

5.  Equine PBMC Cytokines Profile after In Vitro α- and γ-EHV Infection: Efficacy of a Parapoxvirus Ovis Based-Immunomodulator Treatment.

Authors:  Erika S Hue; Eric A Richard; Christine I Fortier; Guillaume D Fortier; Romain Paillot; Rudiger Raue; Stéphane L Pronost
Journal:  Vaccines (Basel)       Date:  2017-09-19

6.  Interferon Gamma Inhibits Equine Herpesvirus 1 Replication in a Cell Line-Dependent Manner.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Pathogens       Date:  2021-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.